Table 1. Comparison of apoptosis and necroptosis 49, 54 .
Features | Apoptosis | Necroptosis (a major form of regulated necrosis) |
---|---|---|
Cytoplasmic shrinkage | Yes | No |
Chromatin condensation | Yes | Mild |
Nuclear fragmentation | Yes | No |
Membrane blebbing | Yes | No |
Shedding of apoptotic bodies | Yes | No |
Swelling of organelles | No | Yes |
Lysosomal membrane permeabilization | No | Yes |
Plasma membrane permeabilization | No | Yes |
Caspase activation | Yes | No |
Key regulators in pathway | Bid, Bax/Bak; cytochrome c; Apaf-1; caspase-9; caspase-8/10; FADD; RIP1 | RIP1, RIP3, MLKL |
Executors of cell death | Caspase-3; caspase-7 | MLKL trimer and ion channels formation |
Inhibitors | zVAD | Nec-1 (RIP1 kinase inhibitor); GSK-843, GSK-872 and GSK-840 (RIP3 kinase inhibitors); NSA (MLKL inhibitor) |
Physiological and pathological roles | Controlling cell numbers during embryogenesis and homeostasis, immune regulation, and pathogen defense. Inhibition of apoptosis may result in cancers, autoimmune diseases, inflammatory diseases, and viral infections | Virus infection, TNF-mediated hypothermia and systemic inflammation, ischemic reperfusion injury, neurodegeneration, Gaucher's disease, progressive atherosclerotic lesions, and cancers |
Abbreviations: Nec-1, necrostatin-1; NSA, necrosulfonamide
Note: Necroptosis is a major and most well-studied form of regulated necrosis, but regulated necrosis may also include other forms, such as parthanatos, oxytosis, ferroptosis, NETosis, pyronecrosis, and pyroptosis2